biomolecular
nmr
contribut
routin
everi
step
develop
new
chemic
entiti
ahead
clinic
trial
versatil
nmr
detect
ligand
bind
wide
rang
affin
wide
rang
drug
target
wealth
molecular
inform
metabolom
profil
ex
vivo
vivo
pave
way
broadli
distribut
applic
academia
pharmaceut
industri
proteom
initi
target
select
benefit
nmr
screen
nmr
identifi
lead
compound
capabl
inhibit
proteinprotein
interact
still
one
difficult
develop
task
drug
discoveri
nmr
hardwar
improv
given
access
microgram
domain
phytochemistri
lead
discoveri
novel
bioactiv
natur
compound
steer
medicin
chemist
lead
optimis
process
provid
detail
inform
proteinligand
interact
led
impress
success
develop
novel
drug
studi
biofluid
compositionmetabonom
provid
inform
pharmacokinet
help
toxicolog
safeti
assess
anim
model
system
vivo
magnet
reson
spectroscopi
interrog
metabolit
distribut
live
cell
tissu
increas
precis
significantli
impact
develop
anticanc
neurolog
disord
therapeut
overview
differ
step
recent
drug
discoveri
present
illumin
link
recent
advanc
nmr
methodolog
biomolecular
nmr
contribut
routin
everi
step
develop
new
chemic
entiti
ahead
clinic
trial
versatil
nmr
detect
ligand
bind
wide
rang
affin
wide
rang
drug
target
wealth
molecular
inform
metabolom
profil
ex
vivo
vivo
pave
way
broadli
distribut
applic
academia
pharmaceut
industri
proteom
initi
target
select
benefit
nmr
screen
nmr
identifi
lead
compound
capabl
inhibit
proteinprotein
interact
still
one
difficult
develop
task
drug
discoveri
nmr
hardwar
improv
given
access
microgram
domain
phytochemistri
lead
discoveri
novel
bioactiv
natur
compound
steer
medicin
chemist
lead
optimis
process
provid
detail
inform
proteinligand
interact
led
impress
success
develop
novel
drug
studi
biofluid
compositionmetabonom
provid
inform
pharmacokinet
help
toxicolog
safeti
assess
anim
model
system
vivo
magnet
reson
spectroscopi
interrog
metabolit
distribut
live
cell
tissu
increas
precis
significantli
impact
develop
anticanc
neurolog
disord
therapeut
overview
differ
step
recent
drug
discoveri
present
illumin
link
recent
advanc
nmr
methodolog
tediou
process
drug
discoveri
requir
interdisciplinari
team
play
market
patent
medicin
cultiv
differ
specialist
contribut
step
valu
chain
first
stage
target
select
identif
optimis
valid
drug
administ
safe
process
reli
continu
innov
improv
underli
methodolog
articl
briefli
point
consecut
step
shown
figur
recent
advanc
nmr
spectroscopi
increasingli
contribut
pharmaceut
drug
discoveri
proteom
structur
genom
initi
often
implement
strategi
highthroughput
clone
express
comparison
cellbas
cellfre
express
protocol
see
purif
structur
determin
feed
demand
threedimension
structur
gene
product
xray
crystallographi
nmr
spectroscopi
provid
sourc
experiment
data
high
often
atom
resolut
whether
correl
nmr
spectral
qualiti
success
rate
crystallis
tradit
matter
debat
one
initi
xray
crystallographi
use
sole
method
structur
determin
protein
sampl
subject
finescreen
coarsescreen
crystallis
trial
predict
basi
h
nmr
spectra
differ
initi
statist
analysi
fail
distinguish
hsqc
heteronuclear
singl
quantum
correl
spectra
qualiti
distribut
protein
success
yield
crystal
structur
protein
sampl
whose
hsqc
spectra
qualifi
poor
unfold
crystallis
good
diffract
properti
vice
versa
author
indic
unstructur
moltenglobulelik
protein
poor
hsqc
qualiti
subject
hetno
data
andor
n
transvers
longitudin
relax
analysi
procedur
provid
quantit
data
may
allow
detect
equilibria
fold
unfold
state
partial
fold
charact
solut
state
crystallis
trial
may
drive
sampl
fold
conform
mass
action
effect
anoth
largescal
analysi
result
structur
genom
initi
recommend
methodolog
use
parallel
complementari
success
rate
approach
seem
justifi
given
dramat
improv
speed
nmr
structur
determin
target
select
therapeut
relev
target
diseasemodifi
druggabl
therefor
threedimension
structur
new
protein
target
inspect
energet
focal
point
often
call
hot
spot
surfac
figur
major
contributor
bind
energi
ligand
geometrybas
algorithm
eg
floodfil
algorithm
implement
within
insight
accelri
heurist
search
concav
invagin
simpl
model
obtain
statist
regress
analysi
success
fruitless
nmr
screen
approach
polar
surfac
complex
rough
compact
correspond
protein
pocket
combin
predict
success
rate
druggabl
potenti
target
linear
combin
mention
properti
use
predict
druggabl
new
target
protein
delimit
cost
expens
highthroughput
screen
ht
approach
author
put
forward
use
nmrbase
prescreen
divers
fragment
librari
experiment
assess
valid
gener
druggabl
protein
target
tool
risk
assess
might
prove
handi
spur
intens
research
protein
larg
molecular
weight
complex
could
target
oral
bioavail
drug
especi
given
recent
breakthrough
smallmolecul
disrupt
proteinprotein
interact
select
recent
exampl
given
tabl
case
inhibitor
select
target
singl
downstream
signal
pathway
design
block
enzym
activ
per
se
therefor
indiscrimin
disrupt
downstream
signal
might
reason
gener
aspect
nmr
screen
techniqu
drug
discoveri
subject
sever
recent
publish
review
focu
exampl
publish
combinatori
chemistri
molecular
divers
figur
flow
scheme
contribut
biomolecular
nmr
drug
discoveri
phase
predict
potenti
druggabl
first
step
identifi
possibl
bind
site
protein
surfac
next
characterist
put
site
hydrophob
shape
charg
calcul
submit
numer
equat
weight
coeffici
b
known
statist
analysi
previou
screen
trial
fragmentbas
approach
primari
screen
prove
viabl
identif
lead
molecul
probabl
detect
bind
low
molecular
weight
mw
da
fragment
high
sensit
exce
ligand
mw
da
function
group
fragmentbas
librari
alreadi
includ
synthet
access
start
point
chemic
linkag
followup
screen
biomolecular
nmr
chaperon
drug
discoveri
betz
saxena
schwalb
chemic
buildingblock
fragment
mask
linker
group
use
optimis
step
librari
design
call
fragment
pair
concept
one
consid
fragment
pair
synthesi
screen
fragment
anoth
major
issu
librari
design
identif
reactiv
fals
posit
oxid
alkyl
protein
target
assay
call
alarmnmr
develop
rule
compound
monitor
c
chemic
shift
chang
human
la
antigen
caus
test
compound
mixtur
valid
unwant
reactiv
experi
repeat
presenc
dtt
sever
nmr
strategi
follow
initi
screen
trial
propos
spinlabel
adenin
analogu
use
detect
alloster
ligand
atpbind
drug
target
paramagnet
relax
enhanc
effect
utilis
atpcomplex
magnesium
ion
replac
paramagnet
manganes
ion
method
proxim
potenti
alloster
inhibitor
estim
effect
antagonist
proteinprotein
interact
elegantli
monitor
nmr
spectroscopi
small
protein
eg
kda
bind
larger
one
nmr
reson
vanish
excess
line
broaden
enhanc
relax
effect
larg
macromolecular
complex
initi
nmr
spectrum
small
protein
restor
upon
addit
antagonist
disrupt
proteinprotein
complex
improv
stem
nmr
hardwar
develop
also
report
better
shield
nmr
magnet
combin
cryoprob
technolog
enabl
combin
liquid
chromatographi
nmr
lcnmr
plant
extract
investig
microgram
domain
explor
extraordinari
reservoir
novel
molecul
potenti
medic
use
bind
protein
target
detect
intermolecular
magnetis
transfer
eg
satur
transfer
differ
std
nmr
techniqu
search
novel
antibiot
onflow
lc
hnmr
also
combin
bioassay
sampl
fraction
nmr
spectra
use
barcod
guid
fraction
crude
natur
mixtur
thu
avoid
repetit
biolog
test
reason
multivari
pattern
recognit
appli
complex
nmr
data
obtain
ht
extract
divers
collect
plant
marin
organ
differ
sampl
may
contain
bioactiv
compound
identifi
cluster
togeth
step
toward
autom
analysi
screen
spectra
publish
recent
wavelet
denois
step
appli
screen
data
prior
common
algorithm
data
reduct
cluster
improv
separ
outlier
hit
cluster
repres
spectra
protein
nonbind
ligand
advanc
model
nmr
datadriven
dock
procedur
allow
determin
approxim
structur
biomolecular
complex
rise
precis
n
chemic
shift
perturb
amid
reson
upon
addit
ligand
bind
partner
anoth
protein
biomolecul
see
review
routin
detect
use
princip
map
bind
interfac
data
subject
restraint
dock
method
model
complex
individu
atom
coordin
current
algorithm
allow
incorpor
nmrderiv
data
crosssatur
transfer
experi
nuclear
overhaus
effect
noe
residu
dipolar
coupl
rdc
even
data
deriv
mutat
analysi
aminoacidspecif
label
recent
success
disrupt
proteinprotein
interact
drug
discoveri
sure
fuel
interest
dock
proteinprotein
complex
guid
subsequ
research
applic
tool
model
dock
complex
small
molecul
help
medicin
chemist
judg
structureact
relationship
recent
publish
one
approach
use
approxim
even
weakbind
regim
small
fragment
molecul
anoth
approach
incorpor
nmrnoe
data
measur
tightbind
regim
drug
candid
advanc
optimis
stage
brief
overview
nmr
method
detect
ligand
interact
target
given
tabl
rel
orient
two
competit
ligand
import
design
highaffin
drug
candid
weakli
bound
fragment
nuclear
overhaus
effect
transfer
one
ligand
competit
ligand
two
undergo
rapid
exchang
magnetis
first
ligand
transfer
proton
protein
spread
interact
surfac
spindiffus
replac
second
ligand
pick
correl
peak
ligand
reson
evolv
inform
use
subsequ
linker
design
method
describ
inpharma
proteinmedi
interligand
noe
pharmacophor
map
sar
ilo
structureact
relationship
interligand
nuclear
overhaus
effect
seem
applic
combin
ligand
weakli
bound
common
receptor
solidst
nmr
catch
achiev
solutionst
nmr
membran
protein
neurolog
import
gpcr
transport
ion
pump
target
pharmaceut
drug
discoveri
solidst
nmr
drug
design
still
strongli
reli
bioinformat
analysi
propos
model
refin
input
data
direct
experiment
nmr
signal
ligand
provid
use
inform
locat
within
membran
target
structur
dynam
situat
put
bind
site
review
see
applic
demonstr
ligand
dock
gastric
h
k
atpas
alreadi
success
target
omeprazol
lanzoprazol
pantoprazol
homolog
model
target
protein
gener
templat
atpas
tg
conform
adopt
catalyt
cycl
sever
analogu
known
inhibitor
synthesis
conform
repres
determin
presenc
gastric
h
k
atpas
solidst
nmr
ligand
structur
subsequ
model
put
bind
volum
model
obtain
model
consist
exist
sitedirect
mutagenesi
data
assess
pharmacokinet
common
problem
may
occur
potenti
drug
candid
bind
tightli
serum
albumin
andor
inhibit
modifi
cytochrom
enzym
nmrfeasibl
domain
two
protein
use
investig
possibl
interact
similar
nmr
method
mention
lead
optimis
theobtainedinformationguidesthemedicin
chemist
design
unaccept
vivo
properti
investig
pharmacodynam
highthroughput
nmr
use
screen
biofluid
composit
metabol
evid
drug
toxic
therapeut
progress
analog
method
plant
extract
coupl
lcnmr
techniqu
appli
vivo
magnet
reson
spectroscopi
mr
latest
highfield
instrument
enabl
analysi
metabol
composit
great
spectral
dispers
live
tissu
complementari
ex
vivo
spectra
record
solidst
nmr
tissu
sampl
directli
place
magicanglespin
rotor
besid
benefit
cryoprob
technolog
steadi
progress
made
grow
databas
store
inform
obtain
anim
model
patient
physiolog
variat
due
speci
age
gender
nutrit
state
etc
automat
analys
pattern
recognit
subject
expert
system
thu
metabonom
approach
base
informationrich
spectroscop
data
set
use
evalu
normal
physiolog
variat
investig
drug
safeti
issu
truli
nmr
versatil
techniqu
combin
unpreced
sensit
atom
resolut
emancip
academia
nmr
routin
contribut
differ
aspect
drug
discoveri
pharmaceut
industri
review
readili
avail
nmr
method
outlin
recent
biomolecular
nmr
chaperon
drug
discoveri
betz
saxena
schwalb
contribut
concaten
step
target
valid
select
lead
discoveri
admetoxicolog
improv
hardwar
instrument
togeth
fastgrow
field
bioinformat
push
frontier
amend
target
modern
drug
discoveri
